Moderna and Merck shares plunge following melanoma vaccine data leak
Shares of Moderna and Merck dropped after clinical data regarding a melanoma vaccine reportedly disappointed Wall Street expectations.
Shares of Moderna and Merck dropped after clinical data regarding a melanoma vaccine reportedly disappointed Wall Street expectations.